Rilotumumab
Product Specifications
CAS Number
872514-65-3
Target
C-Met/HGFR
Related Pathways
Tyrosine Kinase/Adaptors
Purity
0.9751
Bioactivity
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
